U.S. Tobacco Stock News

NYSE:EPRT
NYSE:EPRTREITs

Is Essential Properties Realty Trust (EPRT) Still Attractive After Recent Share Price Gains

If you are wondering whether Essential Properties Realty Trust is reasonably priced or starting to look expensive, you are not alone. The stock last closed at US$34.57, with returns of 3.4% over 7 days, 14.8% over 30 days, 15.0% year to date and 12.0% over the past year, which naturally raises questions about what is already reflected in the price. Recent attention on Essential Properties Realty Trust has largely focused on its role as a net lease REIT and how that business model fits into...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

A Look At The RealReal (REAL) Valuation After Strong Q4 Results And 2026 Growth Guidance

The RealReal (REAL) just paired a strong fourth quarter with fresh 2026 guidance, reporting higher year over year revenue, narrower net losses and its first full year of consistently positive adjusted EBITDA. See our latest analysis for RealReal. After this earnings and guidance update, RealReal’s latest share price of $12.13 comes after mixed short term moves, with a 4.30% 1 day share price return but a 17.54% 30 day share price decline, while the 1 year total shareholder return of 111.88%...
NYSE:BIP
NYSE:BIPIntegrated Utilities

Is It Too Late To Consider Brookfield Infrastructure Partners (NYSE:BIP) After 35% One Year Rally?

If you are wondering whether Brookfield Infrastructure Partners is still good value at around US$38.94, the key question is how its current price lines up with what the underlying business might be worth. The unit price has been relatively firm recently, with a 6.3% move over the last 30 days and a 13.5% return year to date, while the 1 year return sits at 35.5% and the 5 year return at 39.8%. These moves sit against an ongoing stream of news about global infrastructure demand, financing...
NYSE:STVN
NYSE:STVNLife Sciences

Stevanato Group (NYSE:STVN) Margin Improvement To 12% Tests Bullish Earnings Narratives

Stevanato Group FY 2025 Earnings Snapshot Stevanato Group (NYSE:STVN) has put another solid quarter on the board for FY 2025, with Q3 revenue of €303.2 million and basic EPS of €0.13, alongside trailing twelve month EPS of €0.52 on €1.17 billion of revenue, capped by 22.6% earnings growth over the past year. The company has seen revenue move from €259.6 million in Q2 2024 to €303.2 million in Q3 2025, while quarterly EPS has ranged between €0.08 and €0.18 over that period, setting up a...
NasdaqGM:STAA
NasdaqGM:STAAMedical Equipment

STAAR Surgical (STAA) Posts US$80.4 Million Annual Loss Testing Turnaround Narratives

STAAR Surgical FY 2025 earnings snapshot STAAR Surgical (STAA) has wrapped up FY 2025 with Q4 revenue of US$57.8 million and a basic EPS loss of US$0.37, keeping the focus firmly on the path back to profitability. The company has seen quarterly revenue range from US$42.6 million to US$94.7 million since the start of 2024, while basic EPS has swung between a loss of US$1.10 and a profit of US$0.20. This sets up a mixed picture on margins that investors may view as an ongoing turnaround story...
NasdaqCM:SRTA
NasdaqCM:SRTAHealthcare

Strata Critical Medical Q4 Loss Underscores Ongoing Profitability Gap Versus Bullish Narratives

Strata Critical Medical (SRTA) has reported its FY 2025 numbers, with Q4 revenue at US$66.8 million and a basic EPS loss of US$0.06. Trailing twelve month revenue came in at US$197.1 million with a full year basic EPS loss of US$0.24. Over recent quarters, the company has reported revenue in a range from US$36.1 million to US$66.8 million, while quarterly basic EPS losses have moved between US$0.04 and US$0.12. This keeps the focus on how efficiently it is converting sales into earnings. With...
NasdaqCM:UFPT
NasdaqCM:UFPTMedical Equipment

Does UFP Technologies' (UFPT) Expanded Intuitive Deal Reframe Its Medical Automation Investment Narrative?

In late February 2026, UFP Technologies, Inc. extended and expanded its manufacturing supply agreement with Intuitive Surgical through December 31, 2029, while also reporting higher fourth-quarter and full-year 2025 sales and earnings compared with the prior year. This combination of a longer-term, higher-volume partnership with a key customer and recent earnings growth adds further visibility to UFP Technologies’ medical device exposure and contracted revenue base. Next, we’ll examine how...
NasdaqGS:HBAN
NasdaqGS:HBANBanks

Should Renewed Analyst Focus On Regional Bank Profit Resilience Require Action From Huntington Bancshares (HBAN) Investors?

In recent days, Huntington Bancshares has been in focus as analysts reassessed U.S. regional banks, highlighting expectations for resilient profits ahead of upcoming earnings. This wave of analyst attention, combined with a more constructive view on regional bank fundamentals, has reinforced Huntington’s positioning within the sector. Now we’ll explore how this renewed analyst confidence in regional banks, especially around profit resilience, could influence Huntington’s investment...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

Same Store Sales Strength Tests Profitability Concerns At National Vision Holdings (EYE)

National Vision Holdings (EYE) has put up a mixed FY 2025 scorecard so far, with Q3 revenue at US$487.3 million, basic EPS of US$0.04 and same store sales growth of 7.7%, set against a trailing twelve month loss of US$3.2 million and basic EPS of roughly US$0.04 loss. Over recent quarters the company has seen revenue range from US$451.7 million in Q2 2024 to US$510.3 million in Q1 2025. Basic EPS has moved from a Q4 2024 loss of US$0.37 per share to a Q1 2025 profit of US$0.18 per share and...
NYSE:AVNT
NYSE:AVNTChemicals

Assessing Avient (AVNT) Valuation As Recent Share Moves Contrast With Mixed Longer Term Returns

Avient stock in focus Avient (AVNT) is drawing fresh attention after recent share price moves, with the stock closing at $39.90. For investors, the latest returns across the month and past 3 months invite a closer look. See our latest analysis for Avient. Avient’s recent share price pullback over the past week sits against a stronger backdrop, with a 30 day share price return of 9.17% and a 90 day share price return of 28.96%. However, the 1 year total shareholder return of a 2.10% decline...
NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) Margin Improvement Challenges Bears Focused On Concentration Risks

Accel Entertainment (ACEL) has wrapped up FY 2025 with fourth quarter revenue of US$341.4 million and EPS of US$0.19, capping a year in which trailing twelve month revenue reached US$1.3 billion and EPS came in at US$0.61. The company has seen quarterly revenue move from US$302.2 million in Q3 2024 to US$341.4 million in Q4 2025, while quarterly EPS stepped up from US$0.06 to US$0.19 over the same stretch, setting the backdrop for investors focused on earnings growth and profit consistency...
NasdaqCM:ALMU
NasdaqCM:ALMUSemiconductor

Is Benchmark’s Renewed Aeluma (ALMU) Rating Quietly Reframing Its AI-Optics Competitive Narrative?

On 3 March 2026, Benchmark reaffirmed its positive analyst rating on Aeluma, Inc., citing Nvidia’s recent optical investments as an important sector reference point for the company’s technology focus. This endorsement underscores how investor attention around Aeluma is increasingly tied to perceived alignment with larger industry players pursuing advanced optical solutions for AI infrastructure. We’ll now examine how Benchmark’s renewed confidence, anchored in Nvidia’s optical investment...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

CrowdStrike (CRWD) First Profitable Quarter Challenges Trailing Loss Narrative

CrowdStrike Holdings (CRWD) FY 2026 results in focus CrowdStrike Holdings (CRWD) has capped FY 2026 with fourth quarter revenue of about US$1.3 billion and basic EPS of US$0.15, alongside trailing twelve month revenue of roughly US$4.8 billion and a trailing basic EPS loss of US$0.65. The company has seen quarterly revenue move from US$1.06 billion in Q4 FY 2025 to US$1.31 billion in Q4 FY 2026, while basic EPS shifted from a loss of US$0.37 to a profit of US$0.15 over the same periods. For...
NYSE:FICO
NYSE:FICOSoftware

FICO Education Push With Banzai And NFCC Meets Premium Valuation

FICO (NYSE:FICO) has partnered with Banzai to bring credit and financial literacy education to more than 70% of U.S. K-12 schools. The collaboration gives millions of students and 150,000 teachers access to credit education tools as part of a broader financial literacy push. Separately, the National Foundation for Credit Counseling (NFCC) is expanding its work with FICO to widen access to debt relief resources that use FICO scores. For investors watching NYSE:FICO, these moves highlight how...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

A Look At BioCryst Pharmaceuticals (BCRX) Valuation After Its Profitability And Revenue Turnaround

BioCryst Pharmaceuticals (BCRX) drew fresh attention after reporting fourth quarter 2025 revenue of US$406.56 million and net income of US$245.85 million, compared with revenue of US$131.53 million and a net loss a year earlier. See our latest analysis for BioCryst Pharmaceuticals. The earnings swing to profitability has coincided with a 29.26% 1 month share price return and a 14.27% year to date share price return. However, the 5 year total shareholder return of a 37.03% decline shows longer...
NYSE:EE
NYSE:EEOil and Gas

Excelerate Energy (EE) Valuation Check After Strong 2025 Sales And Net Income Growth

Excelerate Energy (EE) just paired a fresh set of full year 2025 numbers with investor outreach, giving you new data to assess how its liquefied natural gas focused business is translating into revenue and earnings. See our latest analysis for Excelerate Energy. The latest earnings release and upcoming Jefferies conference appearance come after a strong 90 day share price return of 33.33% and a 3 year total shareholder return of 80.00%. However, the recent 7 day share price pullback of 10.28%...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

A Look At Cogent Communications Holdings (CCOI) Valuation After Recent Share Price Volatility

Event context and recent stock moves Cogent Communications Holdings (CCOI) has been drawing attention after recent share price swings, with the stock showing a 6.7% move over the past day and a 24.9% change over the past week. Those short term moves sit alongside a month decline of 6.6% and a past 3 months gain of 23.1%, while the 1 year total return stands at a 64.9% decline, giving investors mixed signals to assess. See our latest analysis for Cogent Communications Holdings. At a share...
NasdaqGM:ACNT
NasdaqGM:ACNTChemicals

Ascent Industries ACNT Persistent Losses Challenge Bullish Narratives Despite Premium Price To Sales Multiple

Ascent Industries FY 2025 earnings snapshot Ascent Industries (ACNT) closed out FY 2025 with Q4 revenue of US$18.8 million and a basic EPS loss of US$0.11, while trailing 12 month EPS stood at a loss of US$0.58 on revenue of US$74.9 million. The company has seen quarterly revenue move from US$40.7 million in Q4 FY 2024 to US$18.8 million in Q4 FY 2025, alongside basic EPS shifting from a profit of US$0.01 to a loss of US$0.11. This keeps the focus firmly on how efficiently each dollar of...
OTCPK:FTCO
OTCPK:FTCOMetals and Mining

Fortitude Gold (OTCPK:FTCO) Q3 Profit Challenges Bearish Loss Narratives

Fortitude Gold (FTCO) has reported its FY 2025 third quarter with revenue of US$4.7 million, basic EPS of US$0.0096 and net income of US$0.2 million. Trailing 12 month figures sit at US$25.4 million in revenue and a net loss of US$0.5 million with basic EPS at US$0.021. Over recent quarters in FY 2025, revenue has moved from US$6.5 million in Q1 to US$4.9 million in Q2, and EPS has shifted from US$0.0517 in Q1 to US$0.0350 in Q2. Together, these figures give a clearer sense of how the income...
NYSE:KN
NYSE:KNElectronic

Assessing Knowles (KN) Valuation After Strong Recent Share Price Momentum

Why Knowles Is On Investors’ Radar Now Knowles (KN) has drawn fresh attention after recent share price moves, with the stock up over the month and the past 3 months, prompting investors to reassess how its current valuation lines up with fundamentals. See our latest analysis for Knowles. The recent 1 day share price return of 1.37% comes after a weaker 7 day share price return of a 6.53% decline. However, the year to date share price return of 21.28% and 1 year total shareholder return of...
NasdaqGS:VNET
NasdaqGS:VNETIT

Assessing VNET Group (NasdaqGS:VNET) Valuation After Choppy Recent Share Price Performance

Recent performance snapshot VNET Group (NasdaqGS:VNET) has seen mixed share price moves recently, with a 4.1% gain over the past day, a 13.0% decline over the past week, and a 6.0% decline over the past month. Over a longer horizon, the stock shows a 15.9% gain in the past 3 months and a 12.6% gain year to date. The 1 year total return reflects a 17.7% decline, and the 5 year total return reflects a 69.4% decline. See our latest analysis for VNET Group. VNET Group’s recent share price moves...
NasdaqGS:WEYS
NasdaqGS:WEYSRetail Distributors

Weyco Group TTM Margin Decline Reinforces Bearish Profitability Narratives

Weyco Group (WEYS) has wrapped up FY 2025 with fourth quarter revenue of US$76.8 million and basic EPS of US$0.92, alongside net income excluding extra items of US$8.7 million, setting the tone for how the full year is being judged. Over recent quarters the company has seen revenue move from US$80.5 million and EPS of US$1.05 in Q4 2024 to US$73.1 million and US$0.70 in Q3 2025, before landing at the latest levels. This gives investors a clear view of how the top line and EPS have tracked...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

Is It Too Late To Consider EyePoint (EYPT) After A 1‑Year Surge And DCF Upside?

If you are wondering whether EyePoint's share price still reflects fair value after a strong run, you are not alone. This article is here to help you size that up clearly. The stock last closed at US$18.00, with returns of 1.4% over 7 days, 35.4% over 30 days, 3.0% year to date, 173.6% over 1 year, a gain of around 7x over 3 years, and 72.2% over 5 years. Recent news coverage around EyePoint has focused on its position in ophthalmology and its pipeline, which has kept investor attention on...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Is Fortrea Holdings (FTRE) Now An Opportunity After A 38.4% Share Price Slide?

If you are wondering whether Fortrea Holdings' current share price matches its underlying worth, you are not alone. This article will walk through what the numbers actually say about value. Over the past month the stock has seen a sharp 38.4% decline, following a relatively small 0.4% gain over the last 7 days and a 4.7% decline over the past year. This naturally raises questions about whether risk perceptions or return expectations have shifted. Recent news coverage has largely focused on...